MOACM
INDV icon

Mutual of America Capital Management’s Indivior Pharmaceuticals INDV Stock Holding History

Mutual of America Capital Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$435K Buy
14,288
+18
+0.1% +$594 0.01% 1093
2025
Q4 		$512K Buy
+14,270
New +$436K 0.01% 1065

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mutual of America Capital Management's INDV Position: Q1 2026 in Review

Mutual of America Capital Management increased its Indivior Pharmaceuticals (INDV) stake by 0.13% in Q1 2026, buying an estimated $594 and bringing the position to 14,288 shares worth $435K. The position accounts for 0.01% of the portfolio, ranked #1093.

Mutual of America Capital Management first reported a position in INDV in Q4 2025 and has held it in 2 quarters since. The position peaked at $512K in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Mutual of America Capital Management held 14,288 shares of Indivior Pharmaceuticals worth $435K as of Q1 2026.
  • Mutual of America Capital Management bought 18 Indivior Pharmaceuticals shares in Q1 2026, an estimated $594.
  • Indivior Pharmaceuticals made up 0.01% of Mutual of America Capital Management's portfolio in Q1 2026, its #1093 holding.
  • Mutual of America Capital Management first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Mutual of America Capital Management's Indivior Pharmaceuticals position peaked at $512K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.